Organoid Science (CEO Jongman Yoo), a research and development company for organoid-based regenerative therapies, announced on the 8th that it had signed an agreement with Asan Medical Center in Seoul for ‘collaborative research in the clinical field of advanced biopharmaceuticals and advanced regenerative medicine.’
Asan Medical Center in Seoul plans to strengthen research cooperation in the field of advanced biopharmaceuticals between the two institutions by preparing a space for the construction of a new GMP facility for advanced biopharmaceuticals for clinical trials and Organoid Science to construct and operate a GMP facility.
Organoid Science, which is building a GMP dedicated to cutting-edge biopharmaceuticals at the Asan Life Science Research Institute of Asan Medical Center in Seoul, will have the ability to produce drugs for clinical trials as a CMO (contract manufacturer) from the second half of 2023, and Asan Medical Center in Seoul will use this to It is expected that a high-tech biopharmaceutical commercialization system will be established that will conduct consignment production and follow-up clinical trials of research-stage treatments into clinical research drugs.
Therefore, the industry estimates that this agreement between Seoul Asan Medical Center, the largest hospital in Korea, and Organoid Science, which is about to enter clinical trials for organoid-based advanced biopharmaceuticals for the first time in Korea, is significant as a collaboration between leading entities in the medical industry and each field of science and technology. all.
Jongman Yoo, CEO of Organoid Science, said, “We are honored to have signed a cooperation agreement for the construction and operation of an advanced biopharmaceutical GMP facility with Asan Medical Center, which has world-class research capabilities,” adding, “We will actively cooperate in joint research in the clinical field and support the hospital.” “We will do our best to produce clinical trial drugs for researchers.”
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asia Innovation Hub Pangyo Techno Valley 2021’ news